Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Nakamura (Matsusaka, Japan), O. Hataji (Matsusaka, Japan), K. Furuhashi (Matsusaka, Japan), Y. Suzuki (Matsusaka, Japan), T. Sakaguchi (Matsusaka, Japan), K. Ito (Matsusaka, Japan), Y. Nishii (Matsusaka, Japan), O. Taguchi (Matsusaka, Japan), G. Esteban Cesar (Tsu, Japan). Clinical efficacy of sitafloxacin for refractory non-tuberculous mycobacterial lung disease: A single-center retrospective study. 2930

Member's Comments

No comment yet.

Related content which might interest you: Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis. Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan Source: International Congress 2017 – Migrants and screening Year: 2017 Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study Source: Eur Respir J 2015; 46: 1205-1207 Year: 2015 Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea Source: Eur Respir J, 51 (3) 1702467; 10.1183/13993003.02467-2017 Year: 2018 Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases Source: Eur Respir J 2001; 18: Suppl. 33, 443s Year: 2001 Nontuberculous mycobacterial pulmonary disease in anorexic patients with severe malnutrition: a retrospective study Source: Eur Respir J 2004; 24: Suppl. 48, 197s Year: 2004 Non-tuberculous mycobacterium infection in adult patients: a 10-year single-centre experience Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 The treatment outcomes of isoniazid resistant tuberculosis: Multicenter and retrospective study in South Korea Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 First data about the efficacy of moxifloxacin in the treatment of pulmonary tuberculosis – a prospective, randomised study versus INH Source: Annual Congress 2003 - Management of tuberculosis and tubercular infection - old and new considerations Year: 2003 Clinical assessment of oral tuberculosis – a retrospective study Source: Annual Congress 2008 - Difficult tuberculosis cases Year: 2008 Comparative prospective cohort study of the efficacy and safety according to dose of Ceftriaxone in community-acquired pneumonia Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Retrospective study of patients who developed asthma after tuberculosis Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 The efficacy, safety and feasibility of inhaled amikacin for the treatment of refractory non-tuberculous mycobacterial lung diseases Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Pediatric multidrug-resistant tuberculosis in Belgium: a nationwide retrospective cohort study. Source: International Congress 2017 – Update on TB: latest news Year: 2017 Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021